February 26, 2015 8:41 PM ET


Company Overview of Neotropix, Inc.

Company Overview

Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally-occurring virus that attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma, and certain other neuroendocrine cancers. The company was founded in 2003 and is headquartered in Malvern, Pennsylvania.

351 Phoenixville Pike

Malvern, PA 19355

United States

Founded in 2003





Key Executives for Neotropix, Inc.

Chief Executive Officer and Director
Age: 58
Senior Vice President of Clinical Development
Age: 70
Chief Medical Officer
Age: 57
Medical Science Liaison Director
Director of Research and Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioMedomics, Inc. United States
ClinDev Global Inc. United States
Rapa Holdings Inc. United States
DAVA Pharmaceuticals, Inc. United States
Stason Animal Health, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Neotropix, Inc., please visit www.neotropix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.